Anixa Biosciences (ANIX) Earnings Analysis
Anixa Biosciences (ANIX) next reports earnings on 2026-09-10, consensus EPS -0.08 USD. Last quarter (2026-06-10) it beat with EPS -0.07 USD vs -0.1 USD est (+30%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E -11.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ANIX next report earnings?
| Next earnings date | 2026-09-10 |
|---|---|
| Consensus EPS estimate | -0.08 USD |
| Revenue estimate | n/a |
ANIX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-10 | -0.07 USD | -0.1 USD | +30% | Beat |
| 2026-03-09 | -0.08 USD | -0.09 USD | +11.1% | Beat |
| 2026-01-12 | -0.09 USD | -0.08797 USD | -2.3% | Miss |
| 2025-09-10 | -0.07 USD | -0.1 USD | +30% | Beat |
| 2025-05-28 | -0.09 USD | -0.1 USD | +10% | Beat |
| 2025-03-11 | -0.1 USD | -0.1 USD | 0% | Beat |
| 2025-01-10 | -0.09 USD | -0.11 USD | +18.2% | Beat |
| 2024-09-06 | -0.1 USD | -0.11 USD | +9.1% | Beat |
Beat rate: 7/8 (88%) over reported quarters with consensus data.
ANIX valuation and analyst view
| Trailing P/E | -11.80 |
|---|---|
| Trailing EPS | -0.29988 USD |
| Price / book | 8.17 |
| Dividend yield | 0.00% |
| Market cap | 0.12B |
| Analyst consensus | Buy (6 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Anixa Biosciences (ANIX)'s next earnings date?
Anixa Biosciences is next scheduled to report on 2026-09-10, with a consensus EPS estimate of -0.08 USD.
Did ANIX beat earnings last quarter?
In its 2026-06-10 report, ANIX posted EPS of -0.07 USD versus a -0.1 USD estimate — a beat of 30%.
What is ANIX's earnings track record?
Over the last 8 reported quarters with consensus data, ANIX beat estimates 7 times (88%).
What is ANIX's current P/E ratio and EPS?
ANIX trades at a trailing P/E of -11.80 on trailing EPS of -0.2998839043848421 USD.
What do analysts rate ANIX?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell).